114072-73-0Relevant academic research and scientific papers
PREVENTIVES OR REMEDIES FOR MYOCARDITIS, DILATED CARDIOMYOPATHY AND CARDIAC INSUFFICIENCY CONTAINING NF-KAPPA B INHIBITORS AS THE ACTIVE INGREDIENT
-
, (2008/06/13)
The present invention provides a preventive or therapeutic agents for myocarditis, dilated cardiomyopathy and heart failure comprising NF-κB inhibitors as active ingredients.
NF-γ(k)B INHIBITORS CONTAINING AS THE ACTIVE INGREDIENT PHENYLMETHYL BENZOQUINONE
-
, (2008/06/13)
NF-kB inhibitors containing as the active ingredient benzoquinone derivatives represented by general formula (I), hydroquinone compounds thereof or salts of the same, wherein R1, R2 and R3 independently represent each H, C1-5 alkyl or C1-5 alkoxy; R4 represents H, hydroxy-methyl, alkyl or optionally esterified or amidated carboxy; Z is represented by formula (A); and n is from 0 to 6.
2-Arylmethyl-1,4-benzoquinones. I. Novel inhibitors of platelet aggregation: Synthesis and pharmacological evaluation
Suzuki, Kenji,Tatsuoka, Toshio,Murakami, Tomiko,Ishihara, Takafumi,Aisaka, Kazuo,Inoue, Teruyoshi,Ogino, Ryoko,Kuroki, Manami,Miyazaki, Tomoko,Satoh, Fumio,Miyano, Seiji,Sumoto, Kunihiro
, p. 139 - 144 (2007/10/03)
A new series of 2-arylmethyl-1,4-benzoquinones (2) was synthesized for evaluation of their pharmacological activities. These compounds showed significant inhibition of platelet aggregation induced by arachidonic acid (AA) and some of them possessed a prot
